Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 113
Selected: 0
NCT IDTitle
NCT05169177Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
NCT06631872Implementing Surgery School Prehabilitation Using Telehealth
NCT05182931A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
NCT05366153Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
NCT02999893A Study of APR-246 in Oesophageal Cancer
NCT02468687NMP in Relapsed / Refractory Myeloma
NCT00193934Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer
NCT06082128FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their Carers
NCT03900884Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
NCT05063838Perioperative Pharmacogenomic Testing
NCT03569072High Intensity Functional Image Guided Vmat Lung Evasion
NCT01488565A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
NCT05024318NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
NCT01658241Panobinostat Biological Correlates Study
NCT05560659Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
NCT03429387PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia
NCT04234061Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
NCT04720768Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE
NCT07527819Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
NCT07051525Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever
NCT03658447PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)
NCT05263700FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary
NCT05184790LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
NCT01755650Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
NCT04801966Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
NCT00110162Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
NCT05592938Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NCT02385214MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
NCT07434180Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary
NCT02471391ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM)
NCT04430192Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
NCT01676428A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases
NCT03980171Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma
NCT00377195Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma
NCT05053854PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours
NCT05521412EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T
NCT03851146A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours
NCT00206609The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer
NCT06105411Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
NCT04985721A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects
NCT03806764Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient
NCT06414148MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
NCT06882499Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
NCT02303366Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475
NCT00431990A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma
NCT01716364Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT04769817ProsTIC Registry of Men Treated With PSMA Theranostics
NCT03331731A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma
NCT00434239Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
NCT00753727Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma